Use and Accuracy of Inpatient CGM During the COVID-19 Pandemic: An Observational Study of General Medicine and ICU Patients | Zendy

Rebecca Longo | Zendy; H. Elias | Zendy; Mehvish Khan | Zendy; Jane Jeffrie Seley | Zendy

Open Access

Use and Accuracy of Inpatient CGM During the COVID-19 Pandemic: An Observational Study of General Medicine and ICU Patients

Author(s) -

Rebecca Longo,

H. Elias,

Mehvish Khan,

Jane Jeffrie Seley

Publication year - 2021

Publication title -

journal of diabetes science and technology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.039

H-Index - 75

eISSN - 1932-3107

pISSN - 1932-2968

DOI - 10.1177/19322968211008446

Subject(s) - medicine , observational study , emergency medicine , intensive care unit , pandemic , population , covid-19 , glycemic , intensive care medicine , continuous glucose monitoring , medical emergency , health care , diabetes mellitus , disease , environmental health , infectious disease (medical specialty) , endocrinology , economic growth , economics

Continuous glucose monitoring (CGM) is widely used in the outpatient setting for people with diabetes and has been limited to investigational use only for the inpatient population. In April 2020, the US FDA exercised enforcement discretion for the temporary use of inpatient CGM during the pandemic, thus hospitals were presented the opportunity to implement this technology.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research